{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 46,
        "end": 52
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 87,
        "end": 97
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 120,
        "end": 130
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 168,
        "end": 178
      }
    },
    {
      "id": "T8",
      "obj": "Disease",
      "span": {
        "begin": 224,
        "end": 239
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "26039043_12",
  "text": "CONCLUSION : Based on our meta-analysis , the CYP3A4 * 1B genetic polymorphism affects tacrolimus dose requirements and tacrolimus trough concentration/weight-adjusted tacrolimus daily dose ratio within the first year post- transplantation in adult renal transplant recipients , especially in European recipients ( mostly Caucasian ) ."
}
